ACAT inhibitors and their use in the prevention or treatment of fibrosis

Details for Australian Patent Application No. 2007321667 (hide)

Owner SOSEI CO. LTD. CHRONOGEN INC.

Inventors Hihi, Abdelmadjid K.; Branicky, Robyn S.; Jia, Xihua; Hekimi, Siegfried

Agent Griffith Hack

Pub. Number AU-A-2007321667

PCT Pub. Number WO2008/058383

Priority 60/858,349 13.11.06 US; 60/935,753 29.08.07 US

Filing date 13 November 2007

Wipo publication date 22 May 2008

International Classifications

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/058383 Priority application(s): WO2008/058383

17 September 2009 Assignment before Grant

  CHRONOGEN INC.; SOSEI CO. LTD. The application has been assigned to SOSEI CO. LTD.

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007321671-Renin inhibitors

2007321665-Cancerous disease modifying antibodies